Critical Manufacturing Announces Significant Growth in Revenue and MES Orders

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.
Critical Manufacturing, a leading developer of innovative, future-ready manufacturing execution system (MES) software, has announced 2018 end-of-year results, achieving 40% revenue growth and a remarkable 65% growth in product orders year over year. Its exceptional performance reflects the readiness of high-tech industries to adopt the huge benefits offered through Industry 4.0 (I4.0), smart factory technology.
 
Francisco Almada Lobo, CEO at Critical Manufacturing said, “The manufacturing landscape is undergoing significant changes and our MES is an essential element of our customers smart manufacturing strategy. The readiness of our MES for I4.0 makes it a compelling choice which is highly appealing to businesses. It is designed to provide them with a firm foundation and pathway to the huge benefits a smart factory offers in terms of greater efficiency, agility, and increased competitive edge.”
 
The Critical Manufacturing MES has seen great success and growth in its core market segments of electronics, front and back-end semiconductor and medical device manufacturing. The recent strategic investment in the business by ASMPT, the world’s largest hardware and software supplier to the electronics manufacturing industry, has further increased Critical Manufacturing’s global reach and financial strength.
 
Almada Lobo continued, “This is a very exciting time for us. Our orders increase means we are already on track for an exceptional 2019 and now, with the investment from ASMPT, we expect our growth and results going forward to be even stronger. We have also invested in our partner network, which is increasing our representation across adjacent industries such as automotive and aerospace. In response to the huge success we experienced last year, we increased our employee count by 30% in 2018 and will continue our expansion in all areas in 2019.”
 
Critical Manufacturing MES is designed from the ground up to be future ready and help businesses reach the full potential of I4.0. The modular system has a wide range of features to match specific customer requirements, is completely flexible and configurable to reduce total cost of ownership, and has advanced I4.0 capability. It offers a complete digital twin of a plant with 3D visualization. It provides decentralized logic to connect with the Internet of Things (IoT) and to seamlessly handle dynamic processing as associated with a smart factory.
 
Almada Lobo concluded, “Our MES is optimized for global, multi-site manufacturers, an area in which we have had a great deal of success during 2018. We will continue to focus and grow capabilities in our strategic markets and work with our partners to serve new business in adjacent sectors. The unique design and ultimate flexibility of our MES makes it a solid choice to increase efficiency, quality and agility in complex discrete manufacturing industries. It gives businesses the tools they need to meet changing customer demands and compete in the future.”
spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.